Literature DB >> 20651352

Cisplatin augments FAS-mediated apoptosis through lipid rafts.

Cheng-Ri Huang1, Zhe-Xiong Jin, Lingli Dong, Xiao-Peng Tong, Sun Yue, Takafumi Kawanami, Toshioki Sawaki, Tomoyuki Sakai, Miyuki Miki, Haruka Iwao, Akio Nakajima, Yasufumi Masaki, Yoshihiko Fukushima, Masao Tanaka, Yoshimasa Fujita, Hideo Nakajima, Toshiro Okazaki, Hisanori Umehara.   

Abstract

Cisplatin is widely and effectively used for the treatment of various types of cancer. However, its biochemical mechanisms are still unelucidated. Previously, we reported that membrane sphingomyelin (SM) was important for FAS-mediated apoptosis through lipid raft function. In this study, we strikingly show that cisplatin combined with CH11 (anti-FAS antibody, IgM) was able to induce marked apoptosis in SM synthase-restored WR/Fas-SMS1 cells, but not in SM synthase-deficient WR/FAS-SM(-) cells. In addition, we demonstrated that membrane SM played an important role in cisplatin/CH11-induced apoptosis through the classical caspase-dependent pathway, mainly by enhancing the formation of FAS-associated signaling complexes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20651352

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Some Ototoxic Drugs Destroy Cochlear Support Cells Before Damaging Sensory Hair Cells.

Authors:  Dalian Ding; Jianhui Zhang; Haiyan Jiang; Weijun Xuan; Weidong Qi; Richard Salvi
Journal:  Neurotox Res       Date:  2020-01-29       Impact factor: 3.911

2.  Ethanolic extract of Thevetia peruviana flowers enhances TNF-α and TRAIL-induced apoptosis of human cervical cancer cells via intrinsic and extrinsic pathways.

Authors:  Chittima Managit; Hiroaki Sakurai; Ikuo Saiki
Journal:  Oncol Lett       Date:  2017-02-17       Impact factor: 2.967

3.  Sphingomyelin synthase 2 overexpression promotes cisplatin-induced apoptosis of HepG2 cells.

Authors:  Si Luo; Zhen Pan; Shuang Liu; Shujing Yuan; Nianlong Yan
Journal:  Oncol Lett       Date:  2017-10-31       Impact factor: 2.967

4.  MicroRNA-related genetic variants associated with clinical outcomes in early-stage non-small cell lung cancer patients.

Authors:  Xia Pu; Jack A Roth; Michelle A T Hildebrandt; Yuanqing Ye; Hua Wei; John D Minna; Scott M Lippman; Xifeng Wu
Journal:  Cancer Res       Date:  2013-02-01       Impact factor: 12.701

5.  Membrane Transition Temperature Determines Cisplatin Response.

Authors:  Krishnan Raghunathan; Aarif Ahsan; Dipankar Ray; Mukesh K Nyati; Sarah L Veatch
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

6.  Synergistic effect of receptor-interacting protein 140 and simvastatin on the inhibition of proliferation and survival of hepatocellular carcinoma cells.

Authors:  Kun Xia; Panpan Zhang; Jian Hu; Huan Hou; Mingdi Xiong; Junping Xiong; Nianlong Yan
Journal:  Oncol Lett       Date:  2018-01-19       Impact factor: 2.967

Review 7.  Cisplatin-Membrane Interactions and Their Influence on Platinum Complexes Activity and Toxicity.

Authors:  Nuno Martinho; Tânia C B Santos; Helena F Florindo; Liana C Silva
Journal:  Front Physiol       Date:  2019-01-11       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.